Clinical Trials Directory

Trials / Completed

CompletedNCT01115179

Propofol and Perioperative Inflammation

Propofol and/or Its Solvent Modify the Course of Inflammatory Response After Surgical Stress: A Randomized, Controlled, Double-blind Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
79 (actual)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
Male
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

The inflammatory properties of propofol are still under debate. Apolipoprotein A-I (Apo A-I) is involved in the inflammatory process. This study was designed to determine whether and how propofol or its solvent modulate Apo A-I and the inflammatory response after surgical stress. The investigators study hypothesis was that propofol might modify the Apo A-I blood levels, and thus, modulate the postoperative inflammatory course.

Conditions

Interventions

TypeNameDescription
DRUGpropofolInduction with propofol (1.5 to 2mg/kg) and maintenance of anesthesia with propofol 1% (target controlled infusion with concentration levels of 3-5 ug/ml)
DRUGIntralipid 10%Induction of anesthesia with thiopental (3-5mg/kg) and maintenance of anesthesia with isoflurane (end-expired concentration = 0.5%-2.0%) as well as the solvent of propofol 1% (Intralipid 10%; corresponding to a target-controlled infusion of propofol with concentration levels of 3-5ug/ml)
DRUGSalineInduction of anesthesia with thiopental (3-5mg/kg) and maintenance of anesthesia with isoflurane (end-expired concentration = 0.5%-2.0%)

Timeline

Start date
2005-03-01
Primary completion
2005-12-01
Completion
2005-12-01
First posted
2010-05-04
Last updated
2010-05-19

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01115179. Inclusion in this directory is not an endorsement.